Report Detail

Other Global (United States, European Union and China) Insulin Delivery System Market Research Report 2019-2025

  • RnM3702624
  • |
  • 27 August, 2019
  • |
  • Global
  • |
  • 125 Pages
  • |
  • QYResearch
  • |
  • Other

There are many different types of insulin delivery devices available including syringes, pens, jet injectors, oral insulin and pumps which are detailed in the report.

Furthermore, insulin that can be inhaled and other new approached to insulin treatment are at different stages of availability and development throughout the world.
In 2019, the market size of Insulin Delivery System is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of 6.5% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Insulin Delivery System.

This report studies the global market size of Insulin Delivery System, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Insulin Delivery System production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
BD
Novo Nordisk
Sanofi
Eli Lilly
Medtronic
Animas
Beta Bionics
Cellnovo
Copernicus
Dance Biopharm
Debiotech
InsuJet
Insulet
MannKind
Owen Mumford
Roche
SHL
SOOIL
Tandem Diabetes Care
Valeritas
West Pharma
Ypsomed

Market Segment by Product Type
Insulin Syringes
Insulin PumpS
Insulin Pens

Market Segment by Application
Hospitals
Home Care

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Insulin Delivery System status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Insulin Delivery System manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Insulin Delivery System are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Insulin Delivery System Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Insulin Syringes
      • 1.3.3 Insulin PumpS
      • 1.3.4 Insulin Pens
    • 1.4 Market Segment by Application
      • 1.4.1 Global Insulin Delivery System Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Home Care
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Insulin Delivery System Production Value 2014-2025
      • 2.1.2 Global Insulin Delivery System Production 2014-2025
      • 2.1.3 Global Insulin Delivery System Capacity 2014-2025
      • 2.1.4 Global Insulin Delivery System Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Insulin Delivery System Market Size CAGR of Key Regions
      • 2.2.2 Global Insulin Delivery System Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Insulin Delivery System Capacity by Manufacturers
      • 3.1.2 Global Insulin Delivery System Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Insulin Delivery System Revenue by Manufacturers (2014-2019)
      • 3.2.2 Insulin Delivery System Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Insulin Delivery System Market Concentration Ratio (CR5 and HHI)
    • 3.3 Insulin Delivery System Price by Manufacturers
    • 3.4 Key Manufacturers Insulin Delivery System Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Insulin Delivery System Market
    • 3.6 Key Manufacturers Insulin Delivery System Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Insulin Syringes Production and Production Value (2014-2019)
      • 4.1.2 Insulin PumpS Production and Production Value (2014-2019)
      • 4.1.3 Insulin Pens Production and Production Value (2014-2019)
    • 4.2 Global Insulin Delivery System Production Market Share by Type
    • 4.3 Global Insulin Delivery System Production Value Market Share by Type
    • 4.4 Insulin Delivery System Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Insulin Delivery System Consumption by Application

    6 Production by Regions

    • 6.1 Global Insulin Delivery System Production (History Data) by Regions 2014-2019
    • 6.2 Global Insulin Delivery System Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Insulin Delivery System Production Growth Rate 2014-2019
      • 6.3.2 United States Insulin Delivery System Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Insulin Delivery System Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Insulin Delivery System Production Growth Rate 2014-2019
      • 6.4.2 European Union Insulin Delivery System Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Insulin Delivery System Import & Export
    • 6.5 China
      • 6.5.1 China Insulin Delivery System Production Growth Rate 2014-2019
      • 6.5.2 China Insulin Delivery System Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Insulin Delivery System Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Insulin Delivery System Consumption by Regions

    • 7.1 Global Insulin Delivery System Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Insulin Delivery System Consumption by Type
      • 7.2.2 United States Insulin Delivery System Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Insulin Delivery System Consumption by Type
      • 7.3.2 European Union Insulin Delivery System Consumption by Application
    • 7.4 China
      • 7.4.1 China Insulin Delivery System Consumption by Type
      • 7.4.2 China Insulin Delivery System Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Insulin Delivery System Consumption by Type
      • 7.5.2 Rest of World Insulin Delivery System Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 BD
      • 8.1.1 BD Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Insulin Delivery System
      • 8.1.4 Insulin Delivery System Product Introduction
      • 8.1.5 BD Recent Development
    • 8.2 Novo Nordisk
      • 8.2.1 Novo Nordisk Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Insulin Delivery System
      • 8.2.4 Insulin Delivery System Product Introduction
      • 8.2.5 Novo Nordisk Recent Development
    • 8.3 Sanofi
      • 8.3.1 Sanofi Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Insulin Delivery System
      • 8.3.4 Insulin Delivery System Product Introduction
      • 8.3.5 Sanofi Recent Development
    • 8.4 Eli Lilly
      • 8.4.1 Eli Lilly Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Insulin Delivery System
      • 8.4.4 Insulin Delivery System Product Introduction
      • 8.4.5 Eli Lilly Recent Development
    • 8.5 Medtronic
      • 8.5.1 Medtronic Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Insulin Delivery System
      • 8.5.4 Insulin Delivery System Product Introduction
      • 8.5.5 Medtronic Recent Development
    • 8.6 Animas
      • 8.6.1 Animas Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Insulin Delivery System
      • 8.6.4 Insulin Delivery System Product Introduction
      • 8.6.5 Animas Recent Development
    • 8.7 Beta Bionics
      • 8.7.1 Beta Bionics Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Insulin Delivery System
      • 8.7.4 Insulin Delivery System Product Introduction
      • 8.7.5 Beta Bionics Recent Development
    • 8.8 Cellnovo
      • 8.8.1 Cellnovo Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Insulin Delivery System
      • 8.8.4 Insulin Delivery System Product Introduction
      • 8.8.5 Cellnovo Recent Development
    • 8.9 Copernicus
      • 8.9.1 Copernicus Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Insulin Delivery System
      • 8.9.4 Insulin Delivery System Product Introduction
      • 8.9.5 Copernicus Recent Development
    • 8.10 Dance Biopharm
      • 8.10.1 Dance Biopharm Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Insulin Delivery System
      • 8.10.4 Insulin Delivery System Product Introduction
      • 8.10.5 Dance Biopharm Recent Development
    • 8.11 Debiotech
    • 8.12 InsuJet
    • 8.13 Insulet
    • 8.14 MannKind
    • 8.15 Owen Mumford
    • 8.16 Roche
    • 8.17 SHL
    • 8.18 SOOIL
    • 8.19 Tandem Diabetes Care
    • 8.20 Valeritas
    • 8.21 West Pharma
    • 8.22 Ypsomed

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Insulin Delivery System Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Insulin Delivery System Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Insulin Delivery System Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Insulin Delivery System Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Insulin Delivery System Production Forecast by Type
      • 9.7.2 Global Insulin Delivery System Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Insulin Delivery System Sales Channels
      • 10.2.2 Insulin Delivery System Distributors
    • 10.3 Insulin Delivery System Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Summary:
      Get latest Market Research Reports on Insulin Delivery System. Industry analysis & Market Report on Insulin Delivery System is a syndicated market report, published as Global (United States, European Union and China) Insulin Delivery System Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Insulin Delivery System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,620.72
      3,931.08
      5,241.44
      3,047.12
      4,570.68
      6,094.24
      510,958.40
      766,437.60
      1,021,916.80
      274,011.20
      411,016.80
      548,022.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report